These new antivirals don't just block the flu virus — they lock onto it permanently. And they work against bird flu, too.
Pfizer's experimental shot showed more than 70% efficacy, but the trial missed a key statistical threshold—leaving regulators with a complicated decision.
A starting dose of Wegovy now costs $149 a month, down from $1,600 when it launched. Generic versions in India are hitting $14. The GLP-1 gold rush has become a price war — and patients are finally catching a break.
A historic cathedral city is emptying out — not because of government orders, but because residents and visitors are quietly deciding to stay away. Two young people are dead, 34 are infected, and Canterbury's businesses are counting the cost.
The FDA just cleared a 7.2 mg version of Wegovy that triples the active ingredient — and delivered 20.7% weight loss in trials. Novo Nordisk launches in April, chasing Eli Lilly's 57% grip on the market.
A machine learning model trained on hospital death records found that one in six U.S. COVID-19 deaths in 2020-2021 never made it onto official tallies — and the gaps weren't random.
lop News
Carl Sage